Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins: all 582 studies
Page 6 of 6. Open to participants first (72), then studies with results posted, then the rest; newest registration first within each.
- Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 GeneWithdrawnNCT00386399Phase 2
- Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By SurgeryCompletedNCT00373191
- Plastic Stents Compared With Metal Stents in Treating Patients With Malignant Dysphagia Caused by Esophageal Cancer or Gastroesophageal Junction CancerWithdrawnNCT00372450Not applicable
- Sirolimus in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00368914Phase 1
- Safety Study to Determine the Appropriate Dose of Antibody Against Tumor Cells to Best Target Patients With Pancreatic Cancer.TerminatedNCT00364364Early Phase 1
- Transitoriness in Cancer Patients, Psychosocial Issues in Cancer CareCompletedNCT00364078
- One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard TherapyTerminatedNCT00358397Phase 1
- Cyclophosphamide Plus T-Cell Transplantation for Patients With Hematologic MalignanciesTerminatedNCT00356928Phase 1
- Melanoma Biomarker StudyCompletedNCT00348088
- Cyclophosphamide and Rituximab Followed By Vaccine Therapy in Treating Patients With Chronic Lymphocytic LeukemiaWithdrawnNCT00343447Phase 2
- Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase GeneCompletedNCT00303927Phase 2
- Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative DisordersCompletedNCT00293410Phase 1
- Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00293280Phase 2
- Identification of a Screening Tool and Treatment of Lymphedema Secondary to the Management of Breast Cancer StudyTerminatedNCT00282529Not applicable
- Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By SurgeryCompletedNCT00281970Phase 2
- Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck CancerCompletedNCT00281866Phase 2
- Combination Chemotherapy in Treating Patients With Acute Promyelocytic LeukemiaCompletedNCT00276601Phase 2
- Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00276588Phase 2
- Modafinil in Opioid Induced SedationTerminatedNCT00267332Phase 3
- Rituximab and GM-CSF in Treating Patients With Chronic Lymphocytic LeukemiaTerminatedNCT00265915Phase 2
- Infrared Thermography in Finding Skin Lesions in Patients With Kaposi's SarcomaTerminatedNCT00265902Not applicable
- Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic CancerCompletedNCT00265837Phase 3
- Broccoli Sprout Extract in Preventing Lung Cancer in SmokersCompletedNCT00255775Not applicable
- Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic CancerCompletedNCT00255710Phase 1
- Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed GliomasCompletedNCT00253669
- Study of PET Scans and Serotonin in Hot Flashes TreatmentTerminatedNCT00249847Not applicable
- Ex Vivo Expansion of Mafosfamide Purged CD34+ Cells in Patients With Acute LeukemiaTerminatedNCT00245115Phase 1
- Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast CancerCompletedNCT00244959Phase 2
- Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell LymphomaCompletedNCT00242996Phase 2
- Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow TransplantCompletedNCT00238368Phase 2
- Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma MultiformeTerminatedNCT00238277Phase 2
- Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed GliomasCompletedNCT00095771Phase 1
- Microsatellite Analysis of Urinary Sediment in Detecting Bladder CancerCompletedNCT00095589
- A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight LossCompletedNCT00094562Phase 2
- Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast CancerCompletedNCT00093834Phase 1
- Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT00080665Phase 1
- Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast CancerTerminatedNCT00080626Phase 2
- 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic SyndromeCompletedNCT00077558Phase 1
- UCN-01 and Irinotecan in Treating Patients With Advanced Solid TumorsCompletedNCT00047242Phase 1
- Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary GliomaCompletedNCT00027625Phase 1
- Gefitinib in Treating Patients With Recurrent or Progressive CNS TumorsCompletedNCT00025675Phase 2
- Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple MyelomaCompletedNCT00024466Phase 1/2
- CCI-779 in Treating Patients With Malignant GliomaCompletedNCT00022724Phase 1/2
- Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate CancerCompletedNCT00022399Phase 2
- MS-275 in Treating Patients With Hematologic CancerCompletedNCT00015925Phase 1
- Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid LeukemiaCompletedNCT00011934Phase 2
- Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or MeningiomaCompletedNCT00010049Phase 1/2
- Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid TumorsCompletedNCT00007813Phase 1
- Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma MultiformeCompletedNCT00006452Phase 1
- Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain TumorCompletedNCT00006358Phase 2
- Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma MultiformeCompletedNCT00006355Phase 1/2
- Phenylbutyrate and Tretinoin in Treating Patients With Hematologic CancerCompletedNCT00006239Phase 1
- Fenretinide in Treating Patients With Recurrent Malignant GliomaCompletedNCT00006080Phase 2
- Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic CancerCompletedNCT00006042Phase 1
- Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant GliomaCompletedNCT00006025Phase 1
- Celecoxib to Prevent Cancer in Patients With Barrett's EsophagusCompletedNCT00005878Phase 2
- Tipifarnib in Treating Patients With Recurrent or Progressive Malignant GliomaCompletedNCT00005859Phase 1/2
- Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous TreatmentCompletedNCT00005639Phase 1
- Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT00004871Phase 1
- SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation TherapyCompletedNCT00004868Phase 1/2
- Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal HemoglobinuriaCompletedNCT00004464Phase 2
- Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00004073Phase 2
- Gene Therapy in Treating Patients With Recurrent Malignant GliomasCompletedNCT00004041Phase 1
- Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003962Phase 1
- Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic SyndromeCompletedNCT00003961Phase 2
- Donor Bone Marrow Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003960Phase 2
- Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye MelanomaCompletedNCT00003802Phase 2
- Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by SurgeryCompletedNCT00003798Phase 1
- Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With GlioblastomaCompletedNCT00003751Phase 2
- Irinotecan in Treating Patients With Progressive or Recurrent Malignant GliomaCompletedNCT00003616Phase 1/2
- Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic CancersCompletedNCT00003572Phase 2
- Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous LeukemiaTerminatedNCT00003561Phase 2
- Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationCompletedNCT00003538Not applicable
- Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's DiseaseCompletedNCT00003414Phase 3
- Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous LeukemiaCompletedNCT00003340Phase 2
- UCN-01 in Treating Patients With Advanced CancerCompletedNCT00003289Phase 1
- Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic CancerCompletedNCT00003243Phase 1
- Temozolomide and Carmustine in Treating Patients With Anaplastic GliomaCompletedNCT00003176Phase 2
- O(6)-Benzylguanine in Treating Patients With Malignant GliomaCompletedNCT00002971Phase 1
- Penclomedine in Treating Patients With Advanced Solid TumorsCompletedNCT00002915Phase 1
- Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous LeukemiaTerminatedNCT00002778Phase 2
- Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial CancerCompletedNCT00002600Phase 1
← Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins overview and focus areas